je.st
news
Home
› BPS Bioscience, Inc. Introduces New Mutant EZH2 Proteins And Assays Now Available For Cancer And Weaver Syndrome Research
BPS Bioscience, Inc. Introduces New Mutant EZH2 Proteins And Assays Now Available For Cancer And Weaver Syndrome Research
2014-04-30 07:01:39| drugdiscoveryonline News Articles
BPS Bioscience, Inc. (BPS) is excited to announce a unique portfolio of 13 different mutant EZH2 complexes, including several markers for Weaver Syndrome
Tags: research
cancer
proteins
syndrome
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||